New Jersey S 323: Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2022-01-11)

State: New Jersey · Session: 220 · Bill: S 323

Subjects: PHARMACEUTIC

Sponsors: Gopal, Vin, Singleton, Troy, Greenstein, Linda R.

View New Jersey S 323 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.